FiercePharma Manufacturing The FDA opened an office there to do its own inspections after Chinese-made crude heparin was tied to dozens of deaths of dialysis patients in 2008. In 2013, Congress allocated the FDA extra money to expand its operations there, but China has held up ...
Wall Street Journal (blog) The FDA opened an office in China in 2008 after a recall of the heparin blood thinner, which was made with a fake Chinese active ingredient and was linked to 246 deaths in the U.S.. The FDA wants to station more inspectors in China but has been stymied ... and more »
JAMA: The Journal of the American Medical Association Of the 4 reanalyses, 1 found that the experimental treatment (bilavirudin) was significantly more effective and had less bleeding complications than control ( heparin ), 1 whereas the original analysis had shown no significant difference in efficacy, so ... and more »
GlobeNewswire (press release) Heparin is the most widely used anticoagulant and is used for most surgeries and the dissolution of blood clots. Approximately 12 million patients in the U.S. are exposed to heparin annually. Certain patients have life- and limb-threatening allergic ... and more »
KSHB By injecting patients with the blood-thinner Heparin and clot-busting agent TPA, doctors found that they could open up the tiny blood vessels often damaged by frostbite, and otherwise almost impossible to treat. Recent studies have supported the use of ... and more »
Digital Journal Most up-to-date research on "China Heparin Industry Report, 2014-2017" to its huge collection of research reports. Albany, NY -- (ReleaseWire) -- 12/12/2014 -- As the world's major heparin API producer and exporter, China boasts enormous raw materials, ...
TCTMD (registration) Anticoagulation with bivalirudin compared with heparin plus a glycoprotein IIb/IIIa inhibitor (GPI) reduces cardiac mortality and bleeding in STEMI patients undergoing primary PCI at the cost of more acute stent thrombosis, according to a patient-level ... and more »
Digital Journal The Report China Heparin Industry Report, 2014-2017 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz. Albany, NY -- (ReleaseWire) -- 12/31/2014 -- As the ... and more »
